KAY CHRISTINA 4
4 · INTEGRATED BIOPHARMA INC · Filed Nov 25, 2024
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2024-11-25−55,555→ 144,445 totalExercise: $0.09From: 2015-06-02Exp: 2025-06-02→ Common Stock (55,555 underlying) - Award
Common Stock
2024-11-25$0.09/sh+55,555$5,000→ 1,329,022 total
Footnotes (1)
- [F1]55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.